It was shown that after CRH stimulation, the cortisol response varied according to the disease status of the MS patient and was lower in SP-MS patients compared to patients with PP-MS and healthy controls, while a higher β-endorphin/ACTH response was found in RR-MS patients as compared to other groups [34]. Here, CRH is linked to myeloid sarcoma.